Insulin News and Research

RSS

Insulin is a hormone that is needed to convert glucose, starches and other food into energy needed for daily life. Insulin allows cells to use glucose for fuel and is secreted by beta cells in the islets of Langerhans. The release of insulin from the pancreas is stimulated by increased blood glucose, vagal nerve stimulation, and other factors. Insulin is obtained from various animals and available in a variety of preparations. Commercial insulin preparations differ in a number of ways, including differences in the animal species from which they are obtained; their purity, concentration, and solubility; and the time of onset and duration of their biologic action. An oral hypoglycemic agent is not a form of insulin therapy.

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today received a positive opinion from the European Medicines Agency's (EMA) medicinal committee recommending approval of linagliptin, 5 mg, film-coated tablets (to be marketed under the trade name Trajenta® in Europe) for the treatment of adults with type 2 diabetes.

24 Jun 2011

Less than half of primary-care physicians refer all diabetes patients to education programs

While studies have shown that diabetes education programs are crucial in helping individuals living with the disease self-manage their condition, a new study led by Ryerson researchers has found that less than half of primary-care physicians surveyed refer all of their patients with diabetes to these programs.

24 Jun 2011

BioMarin to acquire Pfizer's Ireland manufacturing plant

BioMarin Pharmaceutical Inc. announced today that it has entered into a definitive agreement to acquire a bulk biologics manufacturing plant from Pfizer, located in Shanbally, Cork, Ireland.

24 Jun 2011

GAD vaccine DIAPREV-IT study in high-risk children continues as planned

Despite the disappointing results in trying to treat children suffering from type 1 diabetes with the GAD vaccine, the treatment has not been written off entirely. DIAPREV-IT, the study in which healthy high-risk children are vaccinated, is continuing as planned, and now with more money behind it. "I am still hopeful that the GAD vaccine will work", says Helena Elding Larsson.

23 Jun 2011

Resveratrol may make old age more tolerable, but not prevent it

A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable.

23 Jun 2011

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Fero Industries, Inc. is pleased to announce that it has contracted PNP Pharmaceuticals Inc. as the exclusive global manufacturer of Sucanon®, an oral treatment for type-2 diabetes.

23 Jun 2011

Insights into type I diabetes

A new signal pathway that renders the insulin-releasing beta cell more sensitive to high levels of blood glucose has been discovered by researchers at the Swedish medical university Karolinska Institutet. A second new study reveals a possible way to delay the disease by inhibiting a lipoprotein.

23 Jun 2011

Adding leucine to diets improves insulin sensitivity, pre-diabetic condition and metabolic syndrome

A study led by researchers at the Joslin Diabetes Center suggests that adding the amino acid leucine to their diets may help those with pre-diabetes or metabolic syndrome.

23 Jun 2011

Foods and lifestyles that cause most weight gain: Study

New research shows that eating more potato chips and French fries and watching too much TV are likely to lead to a bigger weight gain over the years than the weight change associated with eating more of other foods.

23 Jun 2011

Sanofi Pasteur establishes new vaccine research and development facility in Canada

Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.

23 Jun 2011

Scientists find altering hormone levels change cellular development in brain

In a study that increases the understanding of the link between fetal development and obesity later in life, researchers at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) found altering the levels of two common hormones, insulin and leptin, in utero changes the cellular development in the region of the brain that regulates appetite.

23 Jun 2011

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.

22 Jun 2011

EC grants marketing authorization to BYDUREON for treatment of type 2 diabetes

Eli Lilly and Company, together with Amylin Pharmaceuticals, Inc. and Alkermes, Inc., announced today that the European Commission has granted marketing authorization to BYDUREON.

21 Jun 2011

FDA's draft guidance document addresses artificial pancreas system for type 1 diabetes

The U.S. Food and Drug Administration today issued draft guidance that will help advance the development and approval of an artificial pancreas system to treat type 1 diabetes in the United States.

21 Jun 2011

Halozyme to present three data on Ultrafast Insulin programs at ADA 2011

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced three upcoming data presentations for it Ultrafast Insulin programs at the American Diabetes Association (ADA) 71st Scientific Sessions taking place June 24-28, 2011 at the San Diego Convention Center.

21 Jun 2011

Atrium to focus on metabolic syndrome, nutrition research

Atrium Innovations Inc., a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based dietary supplements for the health and nutrition industry, today announced a multi-year commitment to nutrition research and to a comprehensive program focusing on metabolic syndrome.

21 Jun 2011

JDRF launches clinical trials network for treatment of type 1 diabetes

Juvenile Diabetes Research Foundation (JDRF) Canada has announced the official launch of its large-scale effort to support clinical trials evaluating new treatments and technologies for type 1 diabetes in Canada.

21 Jun 2011

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA injection and SYMLIN injection, and its investigational diabetes drug candidates BYDUREON and exenatide once monthly at the 71st Scientific Sessions of the American Diabetes Association (ADA) being held in San Diego, CA from June 24 to June 28.

21 Jun 2011

Scientists discover linchpin protein that drives mitochondria's calcium machinery

Mitochondria, those battery-pack organelles that fuel the energy of almost every living cell, have an insatiable appetite for calcium. Whether in a dish or a living organism, the mitochondria of most organisms eagerly absorb this chemical compound.

20 Jun 2011

High rates of type 1 diabetes in Australian children

According to a new report the rate of Type 1 diabetes in Australian children will leap by 10 per cent in the five years to 2013, cementing Australia's position in the top 10 OECD nations for the condition's prevalence. Currently the prevalence of diabetes in Australia ranks seventh-highest among the 30 OECD nations.

17 Jun 2011

Insulin News and Research

Further Reading

EMA CHMP recommends approval of linagliptin for type 2 diabetes

Less than half of primary-care physicians refer all diabetes patients to education programs

BioMarin to acquire Pfizer's Ireland manufacturing plant

GAD vaccine DIAPREV-IT study in high-risk children continues as planned

Resveratrol may make old age more tolerable, but not prevent it

PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon

Insights into type I diabetes

Adding leucine to diets improves insulin sensitivity, pre-diabetic condition and metabolic syndrome

Foods and lifestyles that cause most weight gain: Study

Sanofi Pasteur establishes new vaccine research and development facility in Canada

Scientists find altering hormone levels change cellular development in brain

Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis

EC grants marketing authorization to BYDUREON for treatment of type 2 diabetes

FDA's draft guidance document addresses artificial pancreas system for type 1 diabetes

Halozyme to present three data on Ultrafast Insulin programs at ADA 2011

Atrium to focus on metabolic syndrome, nutrition research

JDRF launches clinical trials network for treatment of type 1 diabetes

Amylin to present data on investigational diabetes drug candidates at ADA annual meeting

Scientists discover linchpin protein that drives mitochondria's calcium machinery

High rates of type 1 diabetes in Australian children

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News